Showing 471-480 of 1697 results for "".
Anti-NMDA Receptor Encephalitis
https://practicalneurology.com/diseases-diagnoses/imaging-testing/anti-nmda-receptor-encephalitis/30674/Recognizing and Responding to Comorbidities in MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/recognizing-and-responding-to-comorbidities-in-ms/30678/MS patients may be at increased risk for certain psychiatric and physical comorbidities. Neurologists can help identify and manage these conditions.In-Focus: Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/in-focus-multiple-sclerosis/30484/Why Early Diagnosis and Strong Patient Partnerships Have Become the Cornerstone of Multiple Sclerosis Treatment.The Texas Experience
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-texas-experience/30630/Experts and care providers in Texas joined forces to develop guidelines that aid diagnosis and care and help elucidate the many types and causes of cognitive impairment.Special Report: Follow-on Biologics
https://practicalneurology.com/columns/practice-management/special-report-follow-on-biologics/30812/Recognize and Prevent Polypharmacy in MS Patients
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/recognize-and-prevent-polypharmacy-in-ms-patients/30836/Minimizing drug-to-drug interactions is paramount in finding an appropriate treatment regimen, ensuring safety, and encouraging good quality of life.Shocking Seizures: What to Know About VNS
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/shocking-seizures-what-to-know-about-vns/30794/A specialist weighs in on when to consider vagus nerve stimulation and the latest research in neurostimulation for epilepsy patientsThe Evolving Role of Neurologists in PFO Closure
https://practicalneurology.com/diseases-diagnoses/stroke/the-evolving-role-of-neurologists-in-pfo-closure/30296/How neurology plays a central role in determining cause and treatment of stroke.Discontinuing Disease-Modifying Therapy in Multiple Sclerosis: Should You Have an Exit Strategy?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/discontinuing-disease-modifying-therapy-in-multiple-sclerosis-should-you-have-an-exit-strategy/30303/Two experts sound off on the implications of indefinite treatment and whether DMTs should be stopped.Global Outcomes Data and Possible New Therapies in the Huntington's Pipeline
https://practicalneurology.com/diseases-diagnoses/movement-disorders/global-outcomes-data-and-possible-new-therapies-in-the-huntingtons-pipeline/30606/Researchers are focused on patient outcomes on a global scale and join clinicians in the vigil for new drug approvals.